Drug Shortage Report for TARO-TADALAFIL
| Report ID | 242666 |
| Drug Identification Number | 02452111 |
| Brand name | TARO-TADALAFIL |
| Common or Proper name | Tadalafil |
| Company Name | SUN PHARMA CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | TADALAFIL |
| Strength(s) | 20MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 4's |
| ATC code | G04BE |
| ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-05-07 |
| Estimated end date | 2024-11-15 |
| Actual end date | 2024-12-12 |
| Shortage status | Resolved |
| Updated date | 2025-01-28 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 126 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2025-01-28 | French | Compare |
| v3 | 2025-01-28 | English | Compare |
| v2 | 2024-11-11 | French | Compare |
| v1 | 2024-11-11 | English | Compare |
Showing 1 to 4 of 4